NDC 0002-3522-11
Zepbound KwikPen 20.8 mg/mL
tirzepatide · INJECTION, SOLUTION
Zepbound KwikPen is a injection, solution containing tirzepatide at a strength of 20.8 mg/mL. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Zepbound KwikPen
- Generic Name
- tirzepatide
- NDC Code (Package)
0002-3522-11- NDC Code (Product)
0002-3522- Manufacturer
- Eli Lilly and Company
- Strength
- 20.8 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA217806
- Drug Class
- Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]; GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 01/20/2026
Recall History
No Recall HistoryView Full Drug Page
Zepbound KwikPen — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.